SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-009380
Filing Date
2012-02-15
Accepted
2012-02-15 16:20:53
Documents
3
Period of Report
2012-02-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v302770_8k.htm 8-K 18381
2 EXHIBIT 99.1 v302770_ex99-1.htm EX-99.1 8731
3 v302770_ex99-2.htm EX-99.2 202862
  Complete submission text file 0001144204-12-009380.txt   231411
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 12616283
SIC: 2836 Biological Products, (No Diagnostic Substances)